Lipids and Atherogenic Indices Fluctuation in Rheumatoid Arthritis Patients on Long-Term Tocilizumab Treatment

Figure 2

Ratios of total cholesterol/high-density lipoprotein (Tot-Chol/HDL-Chol) and low-density lipoprotein-/HDL-cholesterol (LDL-Chol/HDL-Chol) and the atherogenic index of plasma (log triglycerides/HDL-Chol; AIP) at the different time points during tocilizumab treatment. .